Navigation Links
Transition Therapeutics Announces Second Quarter Fiscal 2008 Financial Results
Date:2/12/2008

TORONTO, Feb. 12 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets including Alzheimer's Disease and Diabetes, today announced its financial results for the quarter ended December 31, 2007.

Selected Highlights

-------------------

During the second quarter of fiscal 2008 and up to the date of this press release, the Company achieved the following significant milestones:

ELND005 (AZD-103) - Alzheimer's Disease:

- On January 22, 2008, the Company received a US$5,000,000 milestone

payment from Elan. The milestone payment was triggered by the

initiation of a Phase II clinical study of Alzheimer's disease drug

candidate, ELND005 (AZD-103) on December 21, 2007;

- On December 21, 2007, Elan and Transition Dose First Patient in

Phase II Clinical Study of ELND005 (AZD-103) in Alzheimer's Disease.

The study is a randomized, double-blind, placebo-controlled, dose-

ranging, safety and efficacy study in approximately 340 patients with

mild to moderate Alzheimer's disease. Approximately 65 sites in North

America are expected to participate in the program. The study will

evaluate both cognitive and functional endpoints and each patient's

participation is planned to last approximately 18 months;

- On October 26, 2007, the Company Received the Remaining US$7,500,000

Upfront Payment from Elan. The receipt of US$7,500,000 represents the

second half of the US$15 million upfront payment under the Company's

global collaboration agreement with Elan.

TT-223 (formerly known as "G1") - Diabetes:

- On November 5, 2007, the Company Announced an Update on the Clinical

Development and Partnership activitie
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
2. Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc
3. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2008 Financial Results on Wednesday, November 14, at 8:30 A.M. EST
4. New UIC center to study end-of-life transition
5. Seabrook House Opens Transitional Living Facility: Seabrook West
6. Transition Therapeutics Announces Milestone Payment from Elan
7. Transition Therapeutics Announces Appointment of Vice-President of Business Development
8. Pure Weight Loss Takes Additional Steps To Assure Seamless Transition For Clients
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Bisexuality not a transitional phase among women, according to new research
11. Transition of Behavioral Health Services from WPIC-BV to Heritage Valley Health System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... from the 2010 DePuy hip recall continue to move ... reports. According to documents filed in California’s San ... had been seeking an expedited trial of her DePuy ... (Tilman v. DePuy Orthopaedics, Inc., et al., No. ...
(Date:5/24/2013)... Beach, Delaware (PRWEB) May 24, 2013 ... Mushrush has joined the Dayna Feher team at the ... Mushrush made the Delaware resorts her home in 1975. ... has since worked in all aspects of the real ... and for the past 12 years, a licensed sales ...
(Date:5/24/2013)... May 24 (HealthDay News) -- New research suggests ... among people with insomnia. Every additional hour ... 72 percent drop in the likelihood of moderate ... from the University of Pennsylvania. "We ... between sleep duration and suicide risk," study author, ...
(Date:5/24/2013)... (HealthDay News) -- Drugs commonly used to treat glaucoma ... can interfere with vision, according to a new study. ... are used to reduce eye pressure, have already been ... eye color, the researchers said, suggesting that the new ... Doctors should be conservative when prescribing these drugs, ...
(Date:5/24/2013)... Area homeowners dreaming about owning a hot tub will have ... at factory-direct pricing during the Jacuzzi Hot Tubs Truckload ... Emerald Pool and Patio in Bend, May 24 ... hot tub brand, scheduled the event as part of its ... popular hot tub models at up to 50% savings and ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2Health News:Sleep Duration Linked to Suicidal Thoughts in People With Insomnia 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... United States Marine who lost her arm in a motorcycle accident. She ... arm that is controlled by her own nerves. ,She ... the first that she had been able to eat in a conventional ... was a very big thing for me.” ,Very often ...
... A previous survey of approximately 5,000 United Kingdom ... 34 percent of women reported habitual or regular ... gender, obesity, excessive daytime sleepiness, increasing age, night ... the upper airway. Additional studies report that some ...
... study directed by Mount Sinai School of Medicine ... regimens// might halt or even reverse symptoms of ... Attenuates Alzheimer’s Disease Type Brain Amyloidosis in Squirrel ... will be published in the November 2006 issue ...
... published in Science X-Press, an advanced, online edition of ... immunodeficiency may cause susceptibility// to herpes simplex virus. This ... how genes function in vulnerability to infections. These ... ,In the study, scientists focused on blood ...
... first international guidelines for heart failure patient management, ... for Heart and Lung Transplantation (ISHLT) has been ... Journal of Heart and Lung Transplantation. These complete ... principles failures and will guide practicing physicians and ...
... today announced an innovatory treatment for periodontal disease, that ... but also supports healing and regeneration of tissue and ... periodontal disease affects 8-12% of Americans that needs complicated ... loss, if not treated on time. ,The ...
Cached Medicine News:Health News:Bionic Women –No longer the Stuff of Science Fictio 2Health News:Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military 2Health News:Calorie Restriction May Prevent, Reduce Alzheimer’s Neuropatholog 2Health News:Genetic susceptibility in viral encephalitis 2Health News:New guidelines for global heart patient management 2Health News:New guidelines for global heart patient management 3Health News:Plastic pill – a new treatment for periodontal disease 2
(Date:5/23/2013)... de mayo de 2013  Volcano Corporation (NASDAQ: ... fabricante de herramientas de precisión para terapia guiadas ... la enfermedad vascular periférica y coronaria, anunció hoy ... enosine V asodilator I ndependent ... sesión de ensayo clínico hot line late breaking ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... WILMINGTON, Del. , April 30 ... and Drug Administration (FDA) has approved VIMOVO™ ... of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ... gastric ulcers in patients at risk of developing NSAID-associated ...
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
Cached Medicine Technology:FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 2FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 3FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 4FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 5FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 6FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 7FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 8FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers 9BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3
... Radianse active-RFID-tags can be ... For example, that a device ... complete or that a patient ... Every message from an ID-tag ...
PDC RFID Smart™ Cards can be printed and programmed using a dye-sublimation card printer & programmer....
PDC Smart® Wrist Tag provides read/write and data storage capabilities....
... helps protect infants, patients, staff, and vital ... cost savings, and overall peace of mind ... healthcare facilities., And with HALO, youre not ... solution, but also unique-skin sensing RFID tags ...
Medicine Products: